Clinical Trials Logo

Filter by:
NCT ID: NCT05411315 Completed - Hypotension Clinical Trials

Pragmatic Randomized Trial for Arterial Catheters in the Critical Care Environment

GRACE
Start date: October 17, 2022
Phase: N/A
Study type: Interventional

Investigators will conduct a pragmatic randomized trial to investigate the non-inferiority of restricted use of invasive arterial lines compared to standard arterial line use.

NCT ID: NCT05410964 Completed - Skin Cancer Clinical Trials

Non-Linear Imaging of Skin In Vivo

VISION
Start date: March 28, 2018
Phase:
Study type: Observational

The overall objective of this study is to investigate the potential for the VIO System to display microscopic skin structure in people of different age, sex, race, and skin health.

NCT ID: NCT05410600 Completed - Stroke Clinical Trials

Smart Trainer Arm Ergometry Exercise Training in Individuals Post-Stroke

Start date: March 15, 2023
Phase: N/A
Study type: Interventional

The smart trainer ergometer is comprised of an ergometer with foot and hand pedals, and a visual display in front of the user that can show a variety of scenic pathways. The purpose of this study is to examine changes in power output, oxygen consumption, cognitive function, and quality of life after 8 weeks of smart trainer arm ergometry exercise training among individuals with post-stroke limb impairment.

NCT ID: NCT05410548 Completed - Depression Clinical Trials

Comorbidity Screening and Referral by Prosthetists

Start date: June 9, 2022
Phase: N/A
Study type: Interventional

Lower-limb amputation is associated with life-altering and life-limiting comorbidities. Currently, onus is on primary care providers to diagnose, educate, and refer patients for appropriate management. Recently our laboratory has found, however, that of adults post-amputation seen in an outpatient Limb Loss Clinic presenting with comorbidities, >50% are unaware they have signs of peripheral arterial disease and/or neuropathy. Lack of patient awareness and thus, inadequate comorbidity management, may contribute to suboptimal patient outcomes post-amputation. As a first step in this research line, the proposed project will help determine if comorbidity screening by prosthetists during routine care visits for patients post-amputation may enhance comorbidity awareness, increase patient satisfaction in prosthetic services, and reduce gratuitous prosthetic service utilization. During a follow-up visit, seventy patients following a unilateral lower-limb amputation will be randomized into either a standard-of-care group or a standard of-care plus group. The standard-of-care plus group will receive clinical screenings by a certified prosthetist for peripheral arterial disease, peripheral neuropathy, depression, and high-risk for persistent back pain; patient education on findings; and each participant's primary care provider will receive screening results. The long-term goal of this research is to determine if prosthetists can maximize their utility in an interdisciplinary care team, while enhancing patient outcomes post-amputation.

NCT ID: NCT05410327 Completed - Inflammation Clinical Trials

Health Effects of Traditional Indigenous Chokeberry

Start date: July 13, 2022
Phase: N/A
Study type: Interventional

American Indian populations continue to suffer disproportionately from health problems including such nutrition-related chronic diseases as diabetes and heart disease. This research project will therefore investigate how a traditional Indigenous food called chokeberry (Aronia melanocarpa) impacts epigenetic and metabolic health in relation to resiliency markers in American Indian participants. The process of research with American Indian communities is significant in that it can inform best practices in community engagement orientations, approaches, and models in future research settings.

NCT ID: NCT05409911 Completed - Hepatic Impairment Clinical Trials

A Study to Assess S-217622 in Participants With Mild and Moderate Hepatic Impairment and Healthy Control Participants

Start date: September 13, 2022
Phase: Phase 1
Study type: Interventional

The objective of this study is to assess the pharmacokinetics (PK), safety, and tolerability of S-217622 in participants with mild and moderate hepatic impairment compared with control participants with normal hepatic function.

NCT ID: NCT05409235 Completed - Clinical trials for Diabetic Retinopathy

Nesvategrast (OTT166) in Diabetic Retinopathy (DR)

Start date: July 29, 2022
Phase: Phase 2
Study type: Interventional

This study will evaluate the safety and efficacy of OTT166 Ophthalmic solution in participants with Diabetic Retinopathy.

NCT ID: NCT05409157 Completed - Clinical trials for Healthy Participants

A Study to Evaluate the Drug Levels of BMS-986166 in Healthy Male Participants

Start date: June 17, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the drug levels of BMS-986166 in healthy male participants.

NCT ID: NCT05409105 Completed - Clinical trials for Inflammatory Response

Mangoes and Exercise Inflammation

Start date: August 15, 2022
Phase: N/A
Study type: Interventional

Vigorous exercise bouts result in significant inflammation and muscle soreness. Our research group has published several papers showing that ingestion of various types of fruits enhances inflammation resolution after exercise. Mangoes have a unique nutrient profile (carotenoids, polyphenols, sugars, vitamins) that we hypothesize will mitigate post-exercise inflammation and muscle soreness. This study will examine the effect of 2 cups/day frozen mango ingestion (2 weeks, 330 g/day) in moderating exercise-induced (2.25 h cycling) inflammation and muscle soreness in a randomized crossover trial. Participants will include 20 male and female young adult cyclists (ages 18-60 years) who are capable of cycling 2.25 h in the laboratory on trainers. In random order, the cyclists will supplement their diets with 2 cups/day mangoes with 1 cup water or 1 cup water alone for two weeks, followed by the 2.25-h exercise challenge. Blood and urine samples will be collected pre- and post-2 weeks supplementation. Additional blood samples will be collected immediately post-exercise, and then 1.5-h, 3-h, and 24-h post-exercise. Urine samples will be analyzed for mango-related metabolites to confirm compliance to the supplementation regimen and to establish statistical relationships with inflammation-related outcomes. The blood samples will be analyzed for novel, cutting-edge outcomes related to inflammation including 70 oxylipins, inflammasome activation, and pro-inflammatory cytokines that we have previously shown are sensitive to exercise and nutrition-based interventions. If the data support our hypothesis, mango ingestion will be viewed as a nutritional strategy to counter exercise-induced inflammation by fitness enthusiasts and athletes who exercise vigorously on a regular basis.

NCT ID: NCT05409092 Completed - Clinical trials for Inflammatory Response

Astaxanthin, Exercise Inflammation, Skin Health

Start date: January 19, 2022
Phase: N/A
Study type: Interventional

Vigorous exercise can stress the body. Consuming special types of diet supplements may help the body recover better from exercise. This includes a bright red supplement called astaxanthin that is found in certain algae and causes the pink-red color in salmon. Astaxanthin is an antioxidant and may protect cells from damage and improve the way the immune system functions. The main purpose of this study is to determine if 4 weeks of consuming astaxanthin improves recovery from 2.25 hours of intensive running on a treadmill. This study will also measure whether or not astaxanthin supplementation improves skin health